Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,673,945 papers from all fields of science
Search
Sign In
Create Free Account
Buprenorphine Transdermal Matrix Patch
Known as:
Transdermal Buprenorphine
A transdermal matrix patch containing the synthetic opioid buprenorphine with analgesic and sedative activities. Buprenorphine binds to and activates…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Breakthrough Pain Associated with a Reduction in Serum Buprenorphine Concentration during Dialysis.
A. R. Salili
,
D. Müller
,
Roswitha Skendaj
,
A. Jehle
,
A. Taegtmeyer
Clinical Therapeutics
2016
Corpus ID: 21213266
Review
2012
Review
2012
Low-dose 7-day transdermal buprenorphine in daily clinical practice – perceptions of elderly patients with moderate non-malignant chronic pain
M. Überall
,
G. Müller-Schwefe
Current Medical Research and Opinion
2012
Corpus ID: 206966968
Abstract Objective: To assess patients’ perceptions regarding the low-dose 7-day buprenorphine transdermal patch for treatment of…
Expand
2012
2012
Rifampin Reduces Oral Morphine Absorption: A Case of Transdermal Buprenorphine Selection Based on Morphine Pharmacokinetics
J. Fudin
,
Dania Vanesta Fontenelle
,
A. Payne
Journal of Pain & Palliative Care Pharmacotherapy
2012
Corpus ID: 33362189
ABSTRACT A 51-year-old male was referred to the Stratton Veterans Affairs Medical Center Pain Service after hospital admission…
Expand
2011
2011
Consumption of opioid analgesics in Italy: Light at the end of the tunnel?
A. Chinellato
,
S. Skaper
,
P. Giusti
,
P. Debetto
European Journal of Pain
2011
Corpus ID: 207649796
Review
2008
Review
2008
[Transdermal buprenorphine: a current overview of pharmacological and clinical data].
M. Faymonville
,
D. Libbrecht
Revue Medicale de Liege
2008
Corpus ID: 37344049
Our understanding of the pathophysiologic mechanisms of chronic pain progresses; the complexity of the problem justifies our need…
Expand
2008
2008
[Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain].
M. Tschirner
,
I. Ritzdorf
,
R. Brünjes
MMW, Fortschritte der Medizin
2008
Corpus ID: 27548389
AIM To obtain information on the efficacy, tolerability and safetyofa transdermal buprenorphine patch (Transtec PRO) in patients…
Expand
2006
2006
Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany
Wolfgang Greiner
,
K. Lehmann
,
S. Earnshaw
,
C. Bug
,
R. Sabatowski
European Journal of Health Economics
2006
Corpus ID: 34002406
We carried out a cost-effectiveness evaluation of transdermal fentanyl compared to three other widely used opioids: transdermal…
Expand
2006
2006
Transdermales Buprenorphin in der Schwangerschaft
Dr. E. Ebner
,
M. Wiedmann
Der Schmerz
2006
Corpus ID: 20981605
ZusammenfassungIn den letzten 20 Jahren hat sich das Opioid Buprenorphin als potentes Analgetikum in der Schmerztherapie bewährt…
Expand
2005
2005
Opioidtherapie chronischer Schmerzen bei Kindern
B. Zernikow
,
C. Schiessl
,
C. Wamsler
,
N. Griessinger
,
R. Sittl
Der Schmerz
2005
Corpus ID: 22610597
ZusammenfassungAnhand von 4 Falldarstellungen werden die Besonderheiten der Opioidtherapie bei chronischen Schmerzen im…
Expand
1996
1996
Pharmacokinetic evaluation of transdermal buprenorphine in man
I. Wilding
,
S. Davis
,
+5 authors
J. Nightingale
1996
Corpus ID: 71505403
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE